Chairman Seo hints at possible listing of Celltrion Holdings after mergers Celltrion's Chairman Seo Jung-jin (Celltrion) South Korean pharmaceutical company Celltrion said it aims to log 3.5 trillion won ($2.6 billion) in revenue 2024 once its merger with two affiliates is completed, an increase of over 50 percent from the revenue estimated for this year.During an online meeting with investors on Thursday, Celltrion Founder and Chairman Seo Jung-jin said the company will consider an initial public offering of Celltrion Holdings, the holding firm of Celltrion Group, if necessary after the merger.

https://n.news.naver.com/mnews/article/044/0000249415?sid=104

#naver